NCT00487318View on ClinicalTrials.gov

Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Chronic Hepatitis C
Interventions
DRUG

standard of care

peginterferon/RBV

DRUG

fluvastatin

Add fluvastatin at 20-40 mg/day to standard of care

Trial Locations (1)

73104

Veterans Administration Medical Center, Oklahoma City

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

Bader, Ted, M.D.

INDIV

NCT00487318 - Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin | Biotech Hunter | Biotech Hunter